Document is current
Any future updates will be listed below
-
Authors
Noddeland, Harald
Bremnes, Frida https://orcid.org/0009-0005-3018-2604
Thorud, Anne
Rolid, Katrine https://orcid.org/0000-0003-0670-9312
Kvaerness, Jørn
Jaatun, Ellen Andreassen https://orcid.org/0000-0002-1562-1593
Aas, Sigve Nyvik https://orcid.org/0000-0003-1196-0632
-
Funding
Funding for this research was provided by:
Research Council of Norway (313922)
- License Information
-
More Information
Article History
Received: 23 August 2024
Accepted: 20 November 2024
First Online: 4 December 2024
Declarations
:
: The study was approved by the Regional Committees for Medical and Health Research Ethics in Norway (REK KULMU) and the Norwegian Medicines Agency (NoMA). The study complied with the Declaration of Helsinki and was conducted in accordance with ISO14155:2020– Good clinical practice.
: Written informed consent was obtained from all participants prior to study enrolment.
: Not applicable.
: H.N., A.T. and K.R. declare no competing interests. F.B. and S.N.A. are employed by Mode Sensors, the company developing the sensor tested in the clinical investigation. F.B. and S.N.A. also have stock options in the company. J.K. and E.A.J. are former employees and have shares in the company.
